AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
Adrian Rusu
International
Foto: shutterstock.com/ro
Always see our news on Google
AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
18:53
The congestion in the Panama Canal has increased waiting times to up to 19 days, forcing liquefied gas ships to resort to unusual routes, including bypassing South America.
18:48
Cristina Trăilă is resigning from the position of Deputy Secretary General of the Government on September 15, following accusations of complicity from the DNA.
18:46
Ilie Bolojan stated that a proposal for a civilian director at the SRI could have been accepted if it had been made during the formation of the PSD-PNL-USR-UDMR coalition.
18:28
The government has decided to allocate 135.622 million lei from the Reserve Fund for ROMATSA, ensuring the continuity of air navigation services.
18:24
Flavia Boghiu joins the Ministry of Environment as Secretary of State, announces interim minister Diana Buzoianu
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
